Počet záznamov: 1
nafronyl
SYS d009257 LBL 00000cz--a2200000o--4500 005 20250606214912.0 008 921119|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D03.383.312.620 066 $a 01 $c 03 150 $a nafronyl $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Nafronyloxalate $2 eng 450 $w v $a Naftidrofuryl $2 eng 450 $w v $a nafronyloxalát $2 slo 450 $w v $a naftidrofuryl $2 slo 550 $7 sllk_us_auth*d012702 $Y Serotonin Antagonists $w P $a antagonisty serotonínu 550 $7 sllk_us_auth*d014665 $Y Vasodilator Agents $w P $a látky vazodilatačné 665 $a 91(75); was see under FURANS 1975-90 $2 eng 665 $a Diethylamines (1974) $2 eng 665 $a Furans (1971-1974) $2 eng 665 $a Naphthalenes (1971-1974) $2 eng 665 $a Propionates (1971-1974) $2 eng 680 9-
$i A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors. $2 eng 750 -2
$a Nafronyl $2 eng 980 $x M
Počet záznamov: 1